Rhode Island House Bill H7948

Rhode Island 2026 Regular Session

• Introduced: 2/27/26
• Refer: 2/27/26

Caption

Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.

Impact

The legislation aims to enhance healthcare accessibility by ensuring that financial barriers do not impede access to effective asthma management tools. By eliminating deductibles for these items, the bill seeks to encourage adherence to prescribed treatment plans. This change is anticipated to positively impact many residents, especially those with lower income who may struggle to afford necessary medical supplies. It reflects a growing recognition of the need for affordable healthcare solutions within state law.

Summary

House Bill 7948 proposes a significant update to the state's health insurance regulations by capping the out-of-pocket costs for prescription asthma inhalers, devices, and equipment. The bill specifies that the maximum a covered person would have to pay for these essential medical supplies cannot exceed twenty-five dollars ($25.00) per thirty-day supply. This move is expected to improve access to necessary medications for individuals with respiratory conditions, alleviating some financial burden associated with chronic health management.

Contention

While the bill has received support for addressing the high costs associated with asthma medications, there may be points of contention regarding its implementation and potential implications for health plan operations. Opponents might raise concerns about the implications for insurance providers and the sustainability of such cost caps in the long term. Additionally, the enforcement powers granted to the office of the health insurance commissioner could be debated, with discussions surrounding the extent of regulation and oversight necessary to ensure compliance without creating administrative burdens for health plans.